NCT06619223

Brief Summary

The goal of this observational study is to determine the diagnostic performance of serial ankle arterial Doppler waveform assessments in detecting significant arterial restenosis in patients with Peripheral Arterial Disease (PAD) undergoing lower limb revascularization. The main questions it aims to answer are: Can serial ankle Doppler waveform assessments accurately detect restenosis following revascularization? How cost-effective is this method for long-term patient surveillance? Researchers will compare the results of serial visual Doppler waveform assessments (handheld continuous-wave and pulsed-wave Doppler) with full lower limb arterial duplex ultrasound (DUS) to determine if the Doppler devices provide a comparable diagnostic performance. Participants will: Undergo regular pre- and post-revascularization ankle waveform assessments. Participate in follow-up surveillance visits at 3, 6, and 12 months.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Oct 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Oct 2024Jun 2026

First Submitted

Initial submission to the registry

September 20, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

October 10, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

1 year

First QC Date

September 20, 2024

Last Update Submit

September 27, 2024

Conditions

Keywords

Peripheral Arterial DiseaseSurveillanceultrasound

Outcome Measures

Primary Outcomes (1)

  • Sensitivity of Ankle Doppler Waveform Assessment for Detecting Arterial Restenosis

    The primary outcome is the diagnostic sensitivity of serial ankle Doppler waveform assessments (using continuous-wave and pulsed-wave Doppler) for detecting significant arterial restenosis in the dorsalis pedis artery and posterior tibial artery. The sensitivity of the Doppler waveform results will be compared against the reference standard of a full lower limb duplex ultrasound (DUS), performed at baseline and during follow-up surveillance visits post-revascularisation.

    12 months post-revascularisation

Secondary Outcomes (2)

  • Specificity and Predictive Values of Ankle Doppler Waveform for Arterial Restenosis

    12 months post-revascularisation

  • Cost-Effectiveness of Ankle Doppler Waveform Assessment

    5 years

Interventions

Duplex UltrasoundDIAGNOSTIC_TEST

The primary intervention in this study is the use of ankle Doppler waveform assessment for post-revascularisation surveillance in patients with Peripheral Arterial Disease (PAD). This technique utilises continuous-wave Doppler (CWD) and pulsed-wave Doppler (PWD) to assess the blood flow in the key ankle arteries, including the dorsalis pedis artery (DPA) and posterior tibial artery (PTA).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of adult patients with Peripheral Arterial Disease (PAD) undergoing lower limb revascularisation. The participants will be recruited from three hospitals and will include individuals from diverse demographic backgrounds, focusing on those eligible for surgical revascularisation. The study aims to include both male and female patients, with no restrictions based on race or ethnicity.

You may qualify if:

  • Adult patients (aged 18 and above) with diagnosed Peripheral Arterial Disease (PAD).
  • Patients scheduled for lower limb revascularisation procedures.
  • Patients willing and able to provide informed consent.
  • Patients who can attend follow-up visits at 3, 6, and 12 months post-revascularisation.

You may not qualify if:

  • Patients with non-compressible arteries (due to calcification or other reasons).
  • Patients who are unable to undergo Doppler assessments for any reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Alodayni HM, Smith S, Poushpas S, Swagell K, Mandic D, Johnson NA, Jaffer U, Davies A, Normahani P. Study protocol for a prospective diagnostic accuracy study to assess the feasibility and diagnostic accuracy of serial ankle handheld Doppler waveform assessment (Ankle HHD) for surveillance after lower-limb revascularisation: WAVE study. BMJ Open. 2025 Sep 30;15(9):e107609. doi: 10.1136/bmjopen-2025-107609.

MeSH Terms

Conditions

Peripheral Arterial Disease

Interventions

Ultrasonography, Doppler, Duplex

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Intervention Hierarchy (Ancestors)

Ultrasonography, DopplerUltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Alun H Davies

    Imperial College London

    STUDY CHAIR

Central Study Contacts

Hamidah Mabruk Alodayni

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2024

First Posted

October 1, 2024

Study Start

October 10, 2024

Primary Completion

October 10, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

October 1, 2024

Record last verified: 2024-09